9 articles tagged “chronic-illness”.
Water fasting is gentler and easier to sustain but shallower. Dry fasting is far more powerful per day but aggressive and demanding. Here is how I decide which one a chronically ill person should actually do, and who should not lead with a dry fast.
If doctors have run out of ideas and told you to just live with your chronic illness, you were not imagining it. Here is why the system stops here, what it is actually missing, and the different map that starts with what you can measure yourself.
Thymus peptides (Thymalin, Thymosin alpha-1) are increasingly marketed as thymus regeneration tools. They are not. They provide useful immune-modulatory support during the cleanup phase of the Scorch Protocol, but the structural thymic rebuild requires hGH. This article covers what each peptide actually does.
Thymus peptides (Thymalin, Tα1) provide immune-modulatory support. They do not rebuild thymic tissue mass. The TRIIM trial documented that hGH produces actual thymic regeneration visible on MRI. This article explains the mechanism distinction and why it matters for chronic illness immune recovery.
Long-term carnivore and zero-carb dieting is a common contributing factor in chronic illness onset and a substantial obstacle to recovery. The metabolic transition back to high-carb intake is uncomfortable, frequently produces frightening liver pain that scares patients into reversing the transition, and is what the Scorch Protocol's rebuild phase requires. This article covers the transition.
BPC-157 is one of the most useful regenerative peptides in chronic illness recovery, with documented effects on gut epithelial repair, tight junction restoration, and angiogenesis. This article covers the mechanism, the sequencing that makes it effective, and where it fits in the Scorch Protocol relative to dry fasting and the rebuild phase.
Dry fasting is not a more intense version of water fasting. It is a categorically different intervention that activates a second autophagy pathway water fasting cannot reach. This guide explains the mechanism, the clinical results, the safe protocol, and where dry fasting fits inside the Scorch Protocol recovery arc.
Standard thyroid replacement (levothyroxine, T4) fails to address tissue-level T3 deficiency, the form of thyroid dysfunction that drives chronic illness. This guide explains the mechanism, the slow-release T3 protocol, the temperature-guided dosing framework, and why T3 is the cellular electricity that the Scorch Protocol's other phases require.
Roughly 17% of the general population may meet MCAS criteria; in Long Covid the rate is dramatically higher. The pattern is not coincidence. They share an upstream mechanism, and the protocol that addresses one addresses the other.